RSPH vs XLV

Key Takeaways

• RSPH and XLV both provide pure-play exposure to the U.S. health care sector but employ fundamentally different weighting methodologies: equal weighting versus market-capitalization weighting.
• XLV offers lower costs with an expense ratio of 0.08% compared to RSPH’s 0.40%, making it more cost-efficient for long-term buy-and-hold investors.
• XLV exhibits higher concentration risk, with top holdings such as LLY and JNJ comprising a significant portion of assets, while RSPH’s equal-weight approach provides broader diversification across approximately 60 holdings.
• Both ETFs are passive vehicles tracking S&P indices focused exclusively on health care, with no leverage, inverse strategies, or thematic overlays beyond the sector.
• RSPH’s equal-weight structure may offer relatively more balanced exposure to mid-sized health care companies, potentially reducing the dominance of mega-cap names prevalent in XLV.
• In a sector environment driven by innovation in pharmaceuticals and biotechnology, the structural differences in weighting influence relative risk and return profiles over market cycles.

Introduction

Health care remains a core defensive sector for investors seeking exposure to demographic trends such as aging populations and ongoing medical innovation. RSPH and XLV both target this sector through S&P 500-derived indices, yet they deliver distinct risk-return profiles due to their weighting schemes. They do not compete as direct substitutes but rather offer alternative approaches to the same underlying universe, allowing investors to choose based on preferences for cost, concentration, and diversification within health care.

Invesco S&P 500® Equal Weight Health Care ETF (RSPH) Overview

RSPH tracks the S&P 500® Equal Weight Health Care Index, which applies equal weighting to health care constituents of the S&P 500 Index. The ETF holds approximately 60 stocks and maintains 100% allocation to the health care sector. As an equal-weighted strategy, individual holdings typically represent around 1.5% to 2% of the portfolio, promoting broader representation across sub-industries. The expense ratio stands at 0.40%. RSPH is a passive, rules-based product that rebalances periodically to maintain equal weights, distinguishing it from cap-weighted peers through reduced concentration in the largest companies.

State Street® Health Care Select Sector SPDR® ETF (XLV) Overview

XLV tracks the S&P Health Care Select Sector Index, providing market-capitalization-weighted exposure to health care companies within the S&P 500. The fund typically holds 62 to 63 securities, with 100% allocation to health care. Top holdings often include LLY (approximately 15-16%), JNJ (approximately 10%), ABBV (approximately 7%), and UNH, resulting in the top 10 holdings accounting for roughly 60% of assets. The expense ratio is 0.08%. XLV is a passive ETF with quarterly rebalancing aligned to its underlying index methodology.

Industry and Thematic Backdrop

The health care sector benefits from long-term structural drivers including demographic shifts toward older populations, advances in biotechnology and pharmaceuticals, and steady demand for medical services and equipment. Capital flows into the sector often respond to earnings cycles of large pharmaceutical and managed-care companies, as well as regulatory developments around drug pricing and approvals. Macroeconomic factors such as interest-rate expectations and broader equity-market rotations between growth and defensive sectors influence positioning. Risks include policy changes, patent expirations, and competition within key sub-industries like biotechnology.

Performance and Positioning Comparison

Over recent market cycles, XLV’s market-cap weighting has amplified exposure to high-performing mega-cap names, contributing to stronger relative results during periods of outperformance by companies such as those leading in weight-loss drugs or established pharmaceutical franchises. RSPH’s equal-weight methodology has historically provided a more balanced profile, potentially mitigating drawdowns when large-cap leaders lag. In environments favoring sector rotation toward smaller or mid-tier health care firms, the equal-weight approach may deliver differentiated returns. Both ETFs exhibit lower volatility than the broader market due to the defensive nature of health care, though XLV’s concentration can lead to modestly higher sensitivity to moves in its largest constituents.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening.

Tickeron AI Verdict

Based on observable structural factors including substantially lower expense ratio, established liquidity profile, and alignment with dominant sector leaders driving recent momentum, Tickeron’s AI would currently assign a higher probability of favor to XLV for investors prioritizing cost efficiency and concentrated exposure to leading health care names. RSPH could appeal in scenarios emphasizing diversification within the sector.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations